SCHEMBL21067672

SCHEMBL21067672

COc1ccc(Nc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)n2)cc1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHB4 P54760 2/20 1.00
IGF1R P08069 4/20 0.69
KDR P35968 1/20 0.62
AURKB Q96GD4 1/20 0.62
MAPT P10636 2/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
LMNA P02545 1/20 0.60
GAA P10253 1/20 0.59
PTK2 Q05397 7/20 0.59
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
FGFR1 P11362 1/20 0.56
FGFR2 P21802 1/20 0.56
FGFR4 P22455 1/20 0.56
FGFR3 P22607 1/20 0.56
EGFR P00533 2/20 0.55
JAK2 O60674 1/20 0.53
CDK2 P24941 1/20 0.53
PIK3CA P42336 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4946510 0.82 EPHB4 (0.69) EPHB4IGF1RKDRAURKBPTK2
SCHEMBL14214721 0.81 IGF1R (0.68) EPHB4IGF1RKDRAURKBMEN1
SCHEMBL14214584 0.80 IGF1R (0.66) EPHB4IGF1RKDRAURKBMEN1
SCHEMBL6480192 0.79 IGF1R (0.65) EPHB4IGF1RKDRAURKBPTK2
SCHEMBL4829511 0.79 MAPT (0.75) EPHB4IGF1RMAPTMEN1KMT2A
SCHEMBL4941396 0.78 EPHB4 (0.64) EPHB4IGF1RKDRAURKBMAPT
SCHEMBL14214688 0.78 EPHB4 (0.63) EPHB4IGF1RKDRAURKBPTK2
SCHEMBL1927928 0.76 IGF1R (0.61) EPHB4IGF1RKDRAURKBMAPT
SCHEMBL13955883 0.76 IGF1R (0.59) EPHB4IGF1RKDRAURKBPTK2
SCHEMBL2100643 0.76 BCL6 (0.72) EPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed